EvoNexus Welcomes First Cohort of Applicants for 5G Use Case and AI Incubator Program
EvoNexus, California’s leading nonprofit technology incubator, is welcoming the first cohort of applicants for the 5G incubator program launched in sponsorship with Qualcomm Incorporated, to assist early-stage companies helping to build their 5G use case businesses. Regardless of location, EvoNexus strives to accelerate innovative technology companies with its virtual incubation program, which provides the same long-term residency experience, resources and support.
“5G will drive transformation across industries, fueling a new era of innovation. Qualcomm is developing innovative solutions across the entire 5G value chain and is committed to support the roll out and adoption of 5G,” said Brian Modoff, Executive Vice President, Strategy, M&A and Ventures, Qualcomm Inc. “5G is poised to produce trillions in economic value and we want to ensure that the full potential of 5G is met. Through our EvoNexus sponsorship, we will be supporting early-stage ventures developing new use cases that leverage 5G’s unique capabilities.”
Recommended AI News: Global Enterprises Increasingly Reliant Upon Digital Resiliency During The ‘New Normal’
Following our selection process, companies that are:
- Uniquely enhanced by 5G
- Have a product which will unlock significant value for the 5G ecosystem
- Leverages 5G-specific characteristics
- 5G enabling technologies
will be invited to join our incubator program.
Recommended AI News: IRhythm Technologies Announces NHS Funding After Winning Artificial Intelligence In Health And Care Award
“EvoNexus and Qualcomm have over a decade of experience in accelerating early stage companies building scalable new products for the wireless innovation economy,” said Rory Moore, CEO and co-founder of EvoNexus. “5G/AI will have impact across all industries and provide new opportunities for startups around the globe to create new ventures. EvoNexus has a proven process that enables startups to take their plan from early design to a minimum viable product and early customer traction.”
Recommended AI News: Adona Medical, A Shifamed Portfolio Company, Closes $22 Million In Series A Financing
Comments are closed, but trackbacks and pingbacks are open.